341 related articles for article (PubMed ID: 28536128)
1. Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus.
Goldberg N; Fralick M
CMAJ; 2017 May; 189(20):E724. PubMed ID: 28536128
[No Abstract] [Full Text] [Related]
2. Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.
Bloomgarden ZT
J Diabetes; 2016 Mar; 8(2):175-6. PubMed ID: 26611882
[No Abstract] [Full Text] [Related]
3. [Glucose renal excretion as diabetes treatment: From an old diagnostic method to a new way of treatment].
Dalama B; Biagetti B; Mesa J
Med Clin (Barc); 2016 May; 146(10):460-4. PubMed ID: 26823105
[No Abstract] [Full Text] [Related]
4. Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease.
Wanner C
Nat Rev Nephrol; 2018 Feb; 14(2):78-80. PubMed ID: 29307892
[No Abstract] [Full Text] [Related]
5. Ketonuria/ketonemia associated with the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in type 2 diabetes: A report of three cases from New Delhi, India.
Ghosh A; Gupta R; Misra A
J Diabetes; 2016 Sep; 8(5):738-9. PubMed ID: 27085074
[No Abstract] [Full Text] [Related]
6. Reduced Mortality With Sodium-Glucose Cotransporter-2 Inhibitors in Observational Studies: Avoiding Immortal Time Bias.
Suissa S
Circulation; 2018 Apr; 137(14):1432-1434. PubMed ID: 29610125
[No Abstract] [Full Text] [Related]
7. Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitus.
Mikhail N
South Med J; 2015 Feb; 108(2):91-6. PubMed ID: 25688893
[TBL] [Abstract][Full Text] [Related]
8. [Introduction].
GarcĂa SD
Med Clin (Barc); 2013 Sep; 141 Suppl 2():1-2. PubMed ID: 24444516
[No Abstract] [Full Text] [Related]
9. Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertension.
Bloch MJ
J Am Soc Hypertens; 2016 Mar; 10(3):186-7. PubMed ID: 27408945
[No Abstract] [Full Text] [Related]
10. Sodium glucose transporter 2 inhibition: a new approach to diabetes treatment.
Bloomgarden Z
J Diabetes; 2013 Sep; 5(3):225-7. PubMed ID: 23714218
[No Abstract] [Full Text] [Related]
11. Hot Topics in Primary Care: Role of the Kidney and SGLT-2 Inhibition in Type 2 Diabetes Mellitus.
Miller K; Miller EM
J Fam Pract; 2015 Dec; 64(12 Suppl):S54-8. PubMed ID: 26845015
[TBL] [Abstract][Full Text] [Related]
12. Effects of sodium glucose co-transporter 2 inhibitors on the kidney.
de Albuquerque Rocha N; Neeland IJ; McCullough PA; Toto RD; McGuire DK
Diab Vasc Dis Res; 2018 Sep; 15(5):375-386. PubMed ID: 29963920
[TBL] [Abstract][Full Text] [Related]
13. SGLT2-inhibitors in type-2 diabetes: The remaining questions!
Rajput R; Ved J
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S433-S438. PubMed ID: 28395977
[TBL] [Abstract][Full Text] [Related]
14. European Association for the Study of Diabetes 51st Annual Meeting.
Gao HX; Regier EE; Close KL
J Diabetes; 2016 Mar; 8(2):177-80. PubMed ID: 26606912
[No Abstract] [Full Text] [Related]
15. [The role of SGLT-2 inhibitors in the treatment of type 2 diabetes].
Rupprecht H
MMW Fortschr Med; 2015 Jan; 157(1):55-8. PubMed ID: 25743304
[No Abstract] [Full Text] [Related]
16. Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus.
Carlson CJ; Santamarina ML
Expert Opin Drug Saf; 2016 Oct; 15(10):1401-12. PubMed ID: 27449721
[TBL] [Abstract][Full Text] [Related]
17. What is the place of new SGLT-2 inhibitors in therapy and on the formulary?
Mehr SR; Zimmerman MP
Am J Manag Care; 2014 Mar; 20(4 Spec No.):E1. PubMed ID: 25618509
[No Abstract] [Full Text] [Related]
18. Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
Wittbrodt ET; Eudicone JM; Bell KF; Enhoffer DM; Latham K; Green JB
Am J Manag Care; 2018 Apr; 24(8 Suppl):S138-S145. PubMed ID: 29693360
[TBL] [Abstract][Full Text] [Related]
19. SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.
Bell RM; Yellon DM
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):435-437. PubMed ID: 29030201
[No Abstract] [Full Text] [Related]
20. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
Reed JW
Vasc Health Risk Manag; 2016; 12():393-405. PubMed ID: 27822054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]